224 related articles for article (PubMed ID: 26977024)
21. Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases.
Zhao Y; Bjorbaek C; Moller DE
J Biol Chem; 1996 Nov; 271(47):29773-9. PubMed ID: 8939914
[TBL] [Abstract][Full Text] [Related]
22. RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer.
Serra V; Eichhorn PJ; García-García C; Ibrahim YH; Prudkin L; Sánchez G; Rodríguez O; Antón P; Parra JL; Marlow S; Scaltriti M; Pérez-Garcia J; Prat A; Arribas J; Hahn WC; Kim SY; Baselga J
J Clin Invest; 2013 Jun; 123(6):2551-63. PubMed ID: 23635776
[TBL] [Abstract][Full Text] [Related]
23. Two p90 ribosomal S6 kinase isoforms are involved in the regulation of mitotic and meiotic arrest in Artemia.
Duan RB; Zhang L; Chen DF; Yang F; Yang JS; Yang WJ
J Biol Chem; 2014 Jun; 289(23):16006-15. PubMed ID: 24755224
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells.
Abdulrahman N; Siveen KS; Joseph JM; Osman A; Yalcin HC; Hasan A; Uddin S; Mraiche F
J Pharm Pharmacol; 2020 Nov; 72(11):1536-1545. PubMed ID: 32667058
[TBL] [Abstract][Full Text] [Related]
25. Defining the role of the RSK isoforms in cancer.
Houles T; Roux PP
Semin Cancer Biol; 2018 Feb; 48():53-61. PubMed ID: 28476656
[TBL] [Abstract][Full Text] [Related]
26. Identifying requirements for RSK2 specific inhibitors.
Wright EB; Fukuda S; Li M; Li Y; O'Doherty GA; Lannigan DA
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1798-1809. PubMed ID: 34348556
[TBL] [Abstract][Full Text] [Related]
27. RSK isoforms in cancer cell invasion and metastasis.
Sulzmaier FJ; Ramos JW
Cancer Res; 2013 Oct; 73(20):6099-105. PubMed ID: 24097826
[TBL] [Abstract][Full Text] [Related]
28. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
29. Activation of p90 Rsk1 is sufficient for differentiation of PC12 cells.
Silverman E; Frödin M; Gammeltoft S; Maller JL
Mol Cell Biol; 2004 Dec; 24(24):10573-83. PubMed ID: 15572664
[TBL] [Abstract][Full Text] [Related]
30. Novel potent and selective inhibitors of p90 ribosomal S6 kinase reveal the heterogeneity of RSK function in MAPK-driven cancers.
Aronchik I; Appleton BA; Basham SE; Crawford K; Del Rosario M; Doyle LV; Estacio WF; Lan J; Lindvall MK; Luu CA; Ornelas E; Venetsanakos E; Shafer CM; Jefferson AB
Mol Cancer Res; 2014 May; 12(5):803-12. PubMed ID: 24554780
[TBL] [Abstract][Full Text] [Related]
31. RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.
Zhu J; Li QY; Liu JL; Wei W; Yang HW; Tang W
Oncol Rep; 2015 Dec; 34(6):3156-62. PubMed ID: 26397146
[TBL] [Abstract][Full Text] [Related]
32. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
Han YC; Zeng XX; Wang R; Zhao Y; Li BL; Song M
Ai Zheng; 2007 Jan; 26(1):48-53. PubMed ID: 17222367
[TBL] [Abstract][Full Text] [Related]
33. Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning.
Zeniou M; Ding T; Trivier E; Hanauer A
Hum Mol Genet; 2002 Nov; 11(23):2929-40. PubMed ID: 12393804
[TBL] [Abstract][Full Text] [Related]
34. Identification of RSK substrates using an analog-sensitive kinase approach.
Lizcano-Perret B; Vertommen D; Herinckx G; Calabrese V; Gatto L; Roux PP; Michiels T
J Biol Chem; 2024 Mar; 300(3):105739. PubMed ID: 38342435
[TBL] [Abstract][Full Text] [Related]
35. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.
Yin Y; Sanders AJ; Jiang WG
Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791
[TBL] [Abstract][Full Text] [Related]
36. The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1.
Neise D; Sohn D; Stefanski A; Goto H; Inagaki M; Wesselborg S; Budach W; Stühler K; Jänicke RU
Cell Death Dis; 2013 Oct; 4(10):e859. PubMed ID: 24136223
[TBL] [Abstract][Full Text] [Related]
37. Bacterial Expression, Purification and In Vitro Phosphorylation of Full-Length Ribosomal S6 Kinase 2 (RSK2).
Utepbergenov D; Hennig PM; Derewenda U; Artamonov MV; Somlyo AV; Derewenda ZS
PLoS One; 2016; 11(10):e0164343. PubMed ID: 27732676
[TBL] [Abstract][Full Text] [Related]
38. RSK1 promotes murine breast cancer growth and metastasis.
Czaplinska D; Gorska M; Mieczkowski K; Peszynska-Sularz G; Zaczek AJ; Romanska HM; Sadej R
Folia Histochem Cytobiol; 2018; 56(1):11-20. PubMed ID: 29498411
[TBL] [Abstract][Full Text] [Related]
39. p90 ribosomal S6 kinase 1 (RSK1) isoenzyme specifically regulates cytokinesis progression.
Nam HJ; Lee IJ; Jang S; Bae CD; Kwak SJ; Lee JH
Cell Signal; 2014 Feb; 26(2):208-19. PubMed ID: 24269382
[TBL] [Abstract][Full Text] [Related]
40. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.
Hsu YL; Hou MF; Kuo PL; Huang YF; Tsai EM
Oncogene; 2013 Sep; 32(37):4436-47. PubMed ID: 23045282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
